Pharmosa Biopharm Inc. (6875)
TWSE
26.65
0.00 (0.00%)
Delayed Data
Oct 23, 2026, 01:00 AM
Day's Range
26.6526.65
52 wk Range
26.4561.50
Financial Statements - 6875 - Pharmosa Biopharm Inc.
Revenue
67.26M▼ 59.9%
Net Income
-383.84M▼ 130.3%Net Margin -570.6%
EBITDA
-350.26M▼ 153.0%
Free Cash Flow
-476.82M▼ 62.7%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 67.26M | 167.56M | 314.50M | 0 | - | - |
| Cost of Goods | 54.23M | 40.66M | - | - | - | - |
| Gross Profit | 13.03M | 126.90M | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -402.85M | -218.56M | -2.82M | -271.53M | -259.12M | -187.41M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | -383.84M | -166.65M | 8.45M | -266.50M | -256.47M | -181.69M |
| Income Tax | - | 0 | 0 | 0 | - | - |
| Net Income | -383.84M | -166.65M | 8.45M | -266.50M | -256.47M | -181.69M |
| EPS Basic | -2.97 | -1.32 | 0.07 | -2.7 | -2.953676 | -3.722917 |
| EPS Diluted | -2.97 | -1.32 | 0.07 | -2.7 | -2.953676 | -3.722917 |
| Basic Shares Outstanding | 129.10M | 126.42M | 113.22M | 100.74M | 87.13M | 48.80M |
| Diluted Shares Outstanding | 129.10M | 126.42M | 113.22M | 100.74M | 87.13M | 48.80M |
| Ebit | -381.74M | -164.23M | 11.31M | -265.85M | -255.26M | -177.83M |
| Ebitda | -350.26M | -138.42M | 34.63M | -253.15M | -243.46M | -167.22M |
| Net Income Continuous Operations | -383.84M | -166.65M | 8.45M | -266.50M | -256.47M | -181.69M |
| Minority Interests | - | - | - | 0 | 0 | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
